Lecithin
Imagent (lecithin) is a small molecule pharmaceutical. Lecithin was first approved as Imagent on 2002-05-31. It is used to treat mental fatigue in the USA.
Download report
Favorite
Searched
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dimyristoyl lecithin
+
Perflexane
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| IMAGENT | Vesselon | N-021191 DISCN | 2002-05-31 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| mental fatigue | — | D005222 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
36 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chemical and drug induced liver injury | D056486 | — | 1 | 1 | 1 | — | 3 | ||
| Chronic hepatitis b | D019694 | EFO_0004197 | B18.1 | — | — | — | 1 | — | 1 |
| Alcoholic hepatitis | D006519 | EFO_1001345 | K70.1 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | 3 | 1 | — | 1 | 4 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | 1 | — | 1 | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | — | 1 |
| Panic disorder | D016584 | EFO_0004262 | F41.0 | — | — | 1 | — | — | 1 |
| Social phobia | D000072861 | EFO_1001917 | F40.1 | — | — | 1 | — | — | 1 |
| Agoraphobia | D000379 | EFO_1001872 | F40.0 | — | — | 1 | — | — | 1 |
| Autoimmune hepatitis | D019693 | K75.4 | — | — | 1 | — | — | 1 | |
| Digestive system diseases | D004066 | EFO_0000405 | K92.9 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Endotoxemia | D019446 | — | — | — | — | 1 | 1 | ||
| Metabolic syndrome | D024821 | EFO_0000195 | E88.81 | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Hyperbaric oxygenation | D006931 | — | — | — | — | 1 | 1 | ||
| Tinnitus | D014012 | HP_0000360 | H93.1 | — | — | — | — | 1 | 1 |
| Heart disease risk factors | D000082742 | — | — | — | — | 1 | 1 | ||
| Xerostomia | D014987 | K11.7 | — | — | — | — | 1 | 1 | |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
| Inborn errors metabolism | D008661 | — | — | — | — | 1 | 1 | ||
| Boswellia | D029743 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | LECITHIN |
| INN | perflubron |
| Description | Lecithin (/ˈlɛsɪθɪn/ LESS-ith-in; from the Ancient Greek λέκιθος lékithos "yolk") is a generic term to designate any group of yellow-brownish fatty substances occurring in animal and plant tissues which are amphiphilic – they attract both water and fatty substances (and so are both hydrophilic and lipophilic), and are used for smoothing food textures, emulsifying, homogenizing liquid mixtures, and repelling sticking materials.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | C[N+](C)(C)CCOP(=O)([O-])OCC(COC=O)OC=O |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL2107798 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | Q1D0Q7R4D9 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 28,773 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,338 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more